BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Sun G, Sun X, Li F, Zhao L, Zhong R, Peng Y. The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment. Cancers (Basel) 2020;12:E3332. [PMID: 33187214 DOI: 10.3390/cancers12113332] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Migheli R, Virdis P, Galleri G, Arru C, Lostia G, Coradduzza D, Muroni MR, Pintore G, Podda L, Fozza C, De Miglio MR. Antineoplastic Properties by Proapoptotic Mechanisms Induction of Inula viscosa and Its Sesquiterpene Lactones Tomentosin and Inuviscolide. Biomedicines 2022;10:2739. [DOI: 10.3390/biomedicines10112739] [Reference Citation Analysis]
2 Lacerda Q, Rochani A, Oeffinger B, Liu JB, Wessner CE, Tahmasebi A, Falatah H, Lee P, Leeper DB, Forsberg F, Curry J, Keith SW, O'Kane P, Kaushal G, Wheatley MA, Eisenbrey JR. Tumoral Oxygenation and Biodistribution of Lonidamine Oxygen Microbubbles Following Localized Ultrasound-Triggered Delivery. Int J Pharm 2022;:122072. [PMID: 35932933 DOI: 10.1016/j.ijpharm.2022.122072] [Reference Citation Analysis]
3 Yao W, Wang P, Yang H, Pu X, Yang J. Development of Potent ERα Inhibitors: Effectively Inhibit the Growth of Breast Cancer Cells. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201451] [Reference Citation Analysis]
4 Kasparkova J, Kostrhunova H, Novohradsky V, Ma L, Zhu G, Milaeva ER, Shtill AA, Vinck R, Gasser G, Brabec V, Nazarov AA. Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug? Metallomics 2022;14:mfac048. [PMID: 35759404 DOI: 10.1093/mtomcs/mfac048] [Reference Citation Analysis]
5 Yang L, Li J, Guan Z, Zhang J, Wang X, Tang R. Carrier-free prodrug nanoparticles based on lonidamine and cisplatin for synergistic treatment of breast cancer. J Biomater Appl 2022;:8853282221107951. [PMID: 35689328 DOI: 10.1177/08853282221107951] [Reference Citation Analysis]
6 Shu X, Chen Y, Yan P, Xiang Y, Shi QY, Yin T, Wang P, Liu LH, Shuai X. Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging. J Control Release 2022:S0168-3659(22)00264-4. [PMID: 35550912 DOI: 10.1016/j.jconrel.2022.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang R, Song C, Gao A, Liu Q, Guan W, Mei J, Ma L, Cui D. Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection. Acta Biomater 2022;143:418-27. [PMID: 35219867 DOI: 10.1016/j.actbio.2022.02.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Patel R, Lacerda Q, Oeffinger BE, Eisenbrey JR, Rochani AK, Kaushal G, Wessner CE, Wheatley MA. Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen. Polymers 2022;14:1568. [DOI: 10.3390/polym14081568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sun X, Fan T, Sun G, Zhou Y, Huang Y, Zhang N, Zhao L, Zhong R, Peng Y. 2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation. Biochem Pharmacol 2022;199:115029. [PMID: 35381210 DOI: 10.1016/j.bcp.2022.115029] [Reference Citation Analysis]
10 García-molina P, Sola-leyva A, Luque-navarro PM, Laso A, Ríos-marco P, Ríos A, Lanari D, Torretta A, Parisini E, López-cara LC, Marco C, Carrasco-jiménez MP. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines. Pharmaceutics 2022;14:426. [DOI: 10.3390/pharmaceutics14020426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shang H, Chen Y, Wang C, Zhang S, Wu B, Liang X, Liu Z, Wang Q, Cheng W. RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC. Front Mol Biosci 2022;8:791331. [DOI: 10.3389/fmolb.2021.791331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li H, Xu W, Li F, Zeng R, Zhang X, Wang X, Zhao S, Weng J, Li Z, Sun L. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles. Drug Deliv 2022;29:192-202. [PMID: 34984953 DOI: 10.1080/10717544.2021.2023697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Chen E, Wang T, Zhang J, Zhou X, Niu Y, Liu F, Zhong Y, Huang D, Chen W. Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance. Front Bioeng Biotechnol 2021;9:787320. [PMID: 34912792 DOI: 10.3389/fbioe.2021.787320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen C, Li Q, Xing L, Zhou M, Luo C, Li S, Li L, Huang Y. Co-delivery of mitochondrial targeted lonidamine and PIN1 inhibitor ATRA by nanoparticulate systems for synergistic metastasis suppression. Nano Res . [DOI: 10.1007/s12274-021-3923-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kooshki L, Mahdavi P, Fakhri S, Akkol EK, Khan H. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer. Biofactors 2021. [PMID: 34724274 DOI: 10.1002/biof.1799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kozal K, Jóźwiak P, Krześlak A. Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy. Cancer Control 2021;28:10732748211041243. [PMID: 34554006 DOI: 10.1177/10732748211041243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
17 Costa A, Vale N. Strategies for the treatment of breast cancer: from classical drugs to mathematical models. Math Biosci Eng 2021;18:6328-85. [PMID: 34517536 DOI: 10.3934/mbe.2021316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang L, Li L, Wu X, Wong CKC, Perrotta A, Silvestrini B, Sun F, Cheng CY. mTORC1/rpS6 and p-FAK-Y407 signaling regulate spermatogenesis: Insights from studies of the adjudin pharmaceutical/toxicant model. Semin Cell Dev Biol 2021:S1084-9521(21)00071-9. [PMID: 33867214 DOI: 10.1016/j.semcdb.2021.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen J, Ren F, Cao W, Wu Z, Ju G, Xiao C, Wu W, Gao S, Xu C, Gao Y. Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem. Nanomedicine 2021;34:102370. [PMID: 33713859 DOI: 10.1016/j.nano.2021.102370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shuvalov O, Daks A, Fedorova O, Petukhov A, Barlev N. Linking Metabolic Reprogramming, Plasticity and Tumor Progression. Cancers (Basel) 2021;13:762. [PMID: 33673109 DOI: 10.3390/cancers13040762] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]